These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23881704)

  • 21. Methods for iPS cell generation for basic research and clinical applications.
    Mochiduki Y; Okita K
    Biotechnol J; 2012 Jun; 7(6):789-97. PubMed ID: 22378737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application of induced pluripotent stem (iPS) cells for nerve injury in the central nervous system].
    Kinoshita H
    Masui; 2013 Mar; 62(3):259-64. PubMed ID: 23544326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cells for drug screening.
    Laposa RR
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):240-5. PubMed ID: 21499120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induced pluripotent stem cell-derived hepatocytes as an alternative to human adult hepatocytes.
    Katsuda T; Sakai Y; Ochiya T
    J Stem Cells; 2012; 7(1):1-17. PubMed ID: 23550341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of pluripotency in human cord blood unrestricted somatic stem cells.
    Zaehres H; Kögler G; Arauzo-Bravo MJ; Bleidissel M; Santourlidis S; Weinhold S; Greber B; Kim JB; Buchheiser A; Liedtke S; Eilken HM; Graffmann N; Zhao X; Meyer J; Reinhardt P; Burr B; Waclawczyk S; Ortmeier C; Uhrberg M; Schöler HR; Cantz T; Wernet P
    Exp Hematol; 2010 Sep; 38(9):809-18, 818.e1-2. PubMed ID: 20541586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells.
    Kumar D; Anand T; Kues WA
    Cell Biol Toxicol; 2017 Apr; 33(2):99-112. PubMed ID: 27900567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
    López-González R; Velasco I
    Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cord blood applications in cell therapy: looking back and look ahead.
    Zhou H; Chang S; Rao M
    Expert Opin Biol Ther; 2012 Aug; 12(8):1059-66. PubMed ID: 22681655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia?
    Liras A
    Thromb Res; 2011 Jul; 128(1):8-13. PubMed ID: 21396685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantation site-dependent differences for tracheal regeneration with induced pluripotent stem cells (iPS cells).
    Imaizumi M; Nomoto Y; Sugino T; Otsuki K; Omori K
    Acta Otolaryngol; 2013 Apr; 133(4):405-11. PubMed ID: 23675768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly efficient generation of definitive endoderm lineage from human induced pluripotent stem cells.
    Sekine K; Takebe T; Suzuki Y; Kamiya A; Nakauchi H; Taniguchi H
    Transplant Proc; 2012 May; 44(4):1127-9. PubMed ID: 22564643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of induced pluripotent stem cell transplants: Autologous or allogeneic?
    Li C; Chen S; Zhou Y; Zhao Y; Liu P; Cai J
    Life Sci; 2018 Nov; 212():145-149. PubMed ID: 30290185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo tissue engineering chamber supports human induced pluripotent stem cell survival and rapid differentiation.
    Lim SY; Lee DG; Sivakumaran P; Crombie D; Slavin J; Dottori M; Conley B; Denham M; Leung J; Tee R; Dusting GJ; Pebay A; Dilley RJ
    Biochem Biophys Res Commun; 2012 May; 422(1):75-9. PubMed ID: 22560904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ethical reflections on cell reprogramming].
    Aznar Lucea J; Martínez M
    Cuad Bioet; 2012; 23(78):287-99. PubMed ID: 23130744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].
    Nishiyama T; Takeda S
    Brain Nerve; 2012 Jan; 64(1):39-46. PubMed ID: 22223500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reprogramming of somatic cells.
    Rajasingh J
    Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
    Ito D; Okano H; Suzuki N
    Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.